106 related articles for article (PubMed ID: 24516302)
21. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.
Bennett JM; Begg CB
Cancer Res; 1981 Nov; 41(11 Pt 2):4833-7. PubMed ID: 6945906
[TBL] [Abstract][Full Text] [Related]
22. Dasatinib in chronic myeloid leukemia: a limited Indian experience.
Sharma A; Bahl A; Raina V; Kumar L; Gupta R
Asia Pac J Clin Oncol; 2012 Dec; 8(4):375-9. PubMed ID: 22897916
[TBL] [Abstract][Full Text] [Related]
23. [CHARACTERISTICS OF CHRONIC LEUKOSES (FROM PATHOLOGOANATOMICAL DATA OF THE CENTRAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION OF THE ORDER OF LENIN FOR 1957-1960)].
NEMENOVA NM; ANOKHINA IV
Probl Gematol Pereliv Krovi; 1964 Jan; 9():11-7. PubMed ID: 14162650
[No Abstract] [Full Text] [Related]
24. Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology.
Srinivas KG; Patil S; Shashidhara
Indian J Med Paediatr Oncol; 2013 Jul; 34(3):211-2. PubMed ID: 24516314
[TBL] [Abstract][Full Text] [Related]
25. Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.
Rajappa S; Varadpande L; Paul T; Jacob R; Digumarti R
Leuk Lymphoma; 2008 Mar; 49(3):554-8. PubMed ID: 18297534
[TBL] [Abstract][Full Text] [Related]
26. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
Lancet JE; Uy GL; Newell LF; Lin TL; Ritchie EK; Stuart RK; Strickland SA; Hogge D; Solomon SR; Bixby DL; Kolitz JE; Schiller GJ; Wieduwilt MJ; Ryan DH; Faderl S; Cortes JE
Lancet Haematol; 2021 Jul; 8(7):e481-e491. PubMed ID: 34171279
[TBL] [Abstract][Full Text] [Related]
27. [Glivec in combination with HA regimen for treatment of 20 patients with Ph chromosome positive acute leukemia].
Meng FY; Zheng WY; Liu XL; Song LL; Xu B; Zhang Y; Huang F
Ai Zheng; 2003 Aug; 22(8):840-3. PubMed ID: 12917031
[TBL] [Abstract][Full Text] [Related]
28. Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Löwenberg B; Suciu S; Archimbaud E; Ossenkoppele G; Verhoef GE; Vellenga E; Wijermans P; Berneman Z; Dekker AW; Stryckmans P; Schouten H; Jehn U; Muus P; Sonneveld P; Dardenne M; Zittoun R
Blood; 1997 Oct; 90(8):2952-61. PubMed ID: 9376575
[TBL] [Abstract][Full Text] [Related]
29. Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009.
Rajappa S; Varadpande L; Paul TR; Jacob RT; Digumarti R
Indian J Med Paediatr Oncol; 2013 Jul; 34(3):208-10. PubMed ID: 24516313
[TBL] [Abstract][Full Text] [Related]
30. Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study.
Ravandi F; Assi R; Daver N; Benton CB; Kadia T; Thompson PA; Borthakur G; Alvarado Y; Jabbour EJ; Konopleva M; Takahashi K; Kornblau S; DiNardo CD; Estrov Z; Flores W; Basu S; Allison J; Sharma P; Pierce S; Pike A; Cortes JE; Garcia-Manero G; Kantarjian HM
Lancet Haematol; 2019 Sep; 6(9):e480-e488. PubMed ID: 31400961
[TBL] [Abstract][Full Text] [Related]
31. Report of chronic myeloid leukemia from SEAROC experience, Jaipur over a period of 9 years.
Maru A
Indian J Med Paediatr Oncol; 2013 Jul; 34(3):180-1. PubMed ID: 24516304
[TBL] [Abstract][Full Text] [Related]
32. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Cortes J; Perl AE; Döhner H; Kantarjian H; Martinelli G; Kovacsovics T; Rousselot P; Steffen B; Dombret H; Estey E; Strickland S; Altman JK; Baldus CD; Burnett A; Krämer A; Russell N; Shah NP; Smith CC; Wang ES; Ifrah N; Gammon G; Trone D; Lazzaretto D; Levis M
Lancet Oncol; 2018 Jul; 19(7):889-903. PubMed ID: 29859851
[TBL] [Abstract][Full Text] [Related]
33. Stem cell transplant: An experience from eastern India.
Mukhopadhyay A; Gupta P; Basak J; Chakraborty A; Bhattacharyya D; Mukhopadhyay S; Roy UK
Indian J Med Paediatr Oncol; 2012 Oct; 33(4):203-9. PubMed ID: 23580820
[TBL] [Abstract][Full Text] [Related]
34. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
35. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
36. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
[TBL] [Abstract][Full Text] [Related]
37. [Monitoring the chronic myeloid leukemia patients between 2008 and 2018; the experience of the Hematology and Bone Marrow Transplantation Unit Târgu-Mureș].
Tunyogi AB; Lázár E; Benedek I; Sándor-Kéri J; Zsigmond A; Benedek I
Orv Hetil; 2019 Jan; 160(2):67-72. PubMed ID: 30616371
[TBL] [Abstract][Full Text] [Related]
38. Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India.
Kanakasetty GB; Kuntejowdahalli L; Thanky AH; Dasappa L; Jacob LA; Mallekavu SB; Kumari P
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):52-59. PubMed ID: 27743980
[TBL] [Abstract][Full Text] [Related]
39. Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India.
Ganguly S; Pushpam D; Mian A; Chopra A; Gupta R; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e437-e444. PubMed ID: 32247650
[TBL] [Abstract][Full Text] [Related]
40. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Rowe JM; Kim HT; Cassileth PA; Lazarus HM; Litzow MR; Wiernik PH; Tallman MS
Cancer; 2010 Nov; 116(21):5012-21. PubMed ID: 20629023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
